1887
Volume 2015, Issue 4
  • ISSN: 2305-7823
  • E-ISSN:

Abstract

Surgical treatment of coronary heart disease has shown its life saving benefits in millions of patients for more than half a century. Attempts to create less invasive ways to achieve similar results have attracted great attention since the introduction of balloon angioplasty in 1977. The fascination with such techniques was hampered by a 30% recurrence rate and a 5% rate of abrupt closure, requiring emergency bypass surgery in most instances.

Angioplasty lost much of its unpredictability with the introduction of stents in 1986. The use of potent anti-platelet regimes added further safety, but recurrence remained a definite thread until the introduction of anti-mitotic coatings during the early years of this century. Very late thrombosis, however, continues to haunt interventionist and patients. Vanishing poly-lactic acid stents time still fail to exhibit comparable mechanical properties at present. So far bypass surgery has not yet lost its attraction in complicated and diffuse disease, despite its much higher patient discomfort.

Loading

Article metrics loading...

/content/journals/10.5339/gcsp.2015.53
2015-12-09
2019-11-17
Loading full text...

Full text loading...

/deliver/fulltext/gcsp/2015/4/gcsp.2015.53.html?itemId=/content/journals/10.5339/gcsp.2015.53&mimeType=html&fmt=ahah

References

  1. Vineberg AM. Development of an anastomosis between the coronary vessels and a transplanted internal mammary artery. Can Med Assoc J. 1946; 55:2:117119.
    [Google Scholar]
  2. Favaloro RG. Saphenous vein autograft replacement of severe segmental coronary artery occlusion: Operative technique. The Annals of thoracic surgery. 1968;334339.
    [Google Scholar]
  3. Grüntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet. 1978; 1:8058:263.
    [Google Scholar]
  4. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987 Mar; 316:12:701706.
    [Google Scholar]
  5. Adelman AG, Caramori PR, Cohen EA, Chisholm RJ, Côté G, Ducas J, O'Neill BJ, Tcheng JE. The role of glycoprotein IIb/IIIa platelet inhibition in percutaneous coronary intervention in the stent era. Can J Cardiol. 1998 Aug; 14:8:10571066.
    [Google Scholar]
  6. Tamai H, Igaki K, Kyo E, Kosuga K, Kawashima A, Matsui S, Komori H, Tsuji T, Motohara S, Uehata H. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation. 2000 Jul; 102:4:399404.
    [Google Scholar]
  7. Waksman R, Erbel R, Di Mario C, Bartunek J, de Bruyne B, Eberli FR, Erne P, Haude M, Horrigan M, Ilsley C, Böse D, Bonnier H, Koolen J, Lüscher TF, Weissman NJ. PROGRESS-AMS (Clinical Performance Angiographic Results of Coronary Stenting with Absorbable Metal Stents) Investigators, Early- and long-term intravascular ultrasound and angiographic findings after bioabsorbable magnesium stent implantation in human coronary arteries. JACC Cardiovasc Interv. 2009 Apr; 2:4:312320.
    [Google Scholar]
  8. Ormiston JA, Webster M, Armstrong G. First-in-human implantation of a fully bioabsorbable drug-eluting stent: The BVS poly-L-lactic acid everolimus-eluting coronary stent. Catheter Cardiovasc Interv. 2007 Jan; 69:1:128131.
    [Google Scholar]
  9. Kereiakes DJ, Ellis SG, Popma JJ, Fitzgerald PJ, Samady H, Jones-McMeans J, Zhang Z, Cheong WF, Su X, Ben-Yehuda O, Stone GW. Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: Design of and rationale for the ABSORB III randomized trial. Am Heart J. 2015 Oct; 170:4:641651.
    [Google Scholar]
  10. Shiomi H, Morimoto T, Furukawa Y, Nakagawa Y, Tazaki J, Sakata R, Okabayashi H, Hanyu M, Shimamoto M, Nishiwaki N, Komiya T, Kimura T. CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2). Am J Cardiol. 2015 Jul 1; 116:1:5965.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/gcsp.2015.53
Loading
/content/journals/10.5339/gcsp.2015.53
Loading

Data & Media loading...

  • Article Type: Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error